In the table below are some comparative financial metrics. In my view TPW is way over valued. These are based on a rolling 12 months to Dec'20. It will be interesting to see how the numbers stack up with August reporting.
Column 1 Column 2 Column 3 Column 4 0 P/E Ratio NPM% ROE% 1 2 NCK 10.7x 23.50% 82.20% 3 ADH 10.8x 10.10% 27.90% 4 JBH 12.1x 4.00% 28.60% 5 PMV 18.4x 14.10% 12.80% 6 TPW 53.7x 7.80% 46.40%
Ann: Early settlement of deferred Mocka consideration, page-7
Add ADH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
0.120(6.25%) |
Mkt cap ! $356.3M | |||
| Open | High | Low | Value | Volume |
| $1.92 | $2.06 | $1.88 | $2.039M | 1.031M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 666 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 7564 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| ADH (ASX) Chart |